Mnemo Therapeutics
Paris
About Mnemo Therapeutics
Mnemo Therapeutics is a biotechnology company that offers to develop immune based therapies, including cell therapies. Its EnfiniT platform is a drug discovery engine that uses a class of antigens with a suite of technologies for tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $90.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2021)
- Website: mnemo-tx.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/mnemo-therapeutics-14856 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.